{"id":"infex-400-mr","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL5483039","moleculeType":null,"molecularWeight":"393.02"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to the 50S subunit of the bacterial ribosome, preventing the translocation of peptides during protein synthesis, which ultimately leads to the death of the bacterial cell.","oneSentence":"Infex 400 MR is a macrolide antibiotic that inhibits bacterial protein synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:15:57.854Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute exacerbations of chronic bronchitis"},{"name":"Mild to moderate chronic bronchitis"}]},"trialDetails":[{"nctId":"NCT03729258","phase":"PHASE3","title":"Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.","status":"UNKNOWN","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2019-05-15","conditions":"Sinusitis, Sinusitis, Acute, Rhinosinusitis","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Infex 400 MR","genericName":"Infex 400 MR","companyName":"Neutec Ar-Ge San ve Tic A.Ş","companyId":"neutec-ar-ge-san-ve-tic-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Infex 400 MR is a macrolide antibiotic that inhibits bacterial protein synthesis. Used for Community-acquired pneumonia, Acute exacerbations of chronic bronchitis, Mild to moderate chronic bronchitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}